Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

BACKGROUND: In the era of personalized cancer medicine, identifying techniques for effectively matching patients to efficacious treatments is a critical step in the treatment process. The advent of anti-cancer immunotherapies necessitates novel approaches to biomarker identification beyond tradition...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Oncol
Asıl Yazarlar: Makkouk, A., Sundaram, V., Chester, C., Chang, S., Colevas, A. D., Sunwoo, J. B., Maecker, H., Desai, M., Kohrt, H. E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Original articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246233/
https://ncbi.nlm.nih.gov/pubmed/27831501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw570
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller